Walleye Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-86,200
Closed -$838K 4889
2025
Q4
$838K Buy
86,200
+26,000
+43% +$221K ﹤0.01% 2583
2025
Q3
$252K Buy
+60,200
New +$385K ﹤0.01% 3149
2024
Q2
Sell
-3,000
Closed -$24.5K 5934
2024
Q1
$24.5K Sell
3,000
-7,700
-72% -$63.1K ﹤0.01% 4875
2023
Q4
$90.2K Buy
+10,700
New +$124K ﹤0.01% 4091

Other funds holding REPL

Walleye Capital's REPL Position: Q1 2026 in Review

Walleye Capital opened a new position in Replimune Group (REPL) in Q1 2026: 71,592 shares worth $548K. The stake represents ﹤0.01% of the portfolio and ranks #2592 among its holdings. This is a return to the name: Walleye Capital previously reported a position in REPL as recently as Q3 2025.

Walleye Capital first reported a position in REPL in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.18M in Q2 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Walleye Capital held 71,592 shares of Replimune Group worth $548K as of Q1 2026.
  • Replimune Group was a new Walleye Capital position in Q1 2026.
  • Replimune Group made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2592 holding.
  • Walleye Capital first reported a position in Replimune Group in Q2 2023 and has held it in 6 quarters since.
  • Walleye Capital's Replimune Group position peaked at $1.18M in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.